1Oguz S, Sargin A, Kelekci S, et al. The role of hormone replacement therapy in endometrial polyp formation[J]. Maturitas, 2005,50 : 231-236.
2McGurqan P, Tayor L J, Dully S R, et al. An immunohistochemical comparison of endometrialpolyps from postmenopausal women exposed and not exposed to HRT[J]. Maturitas,2006,53 (4) :454-461.
3McGurqan P, Tayor L J, Duffy S R, et al. Does tamoxifen therapy aff-ect the hormone receptor expression and cell proliferation indices of endometrial polyps? An immtmohistochemical comparison of endornetrial polyps from postmenopausal women exposed and not exposed to tamoxifen[ J]. Maturitas,2006,54(3 ) :252-259.
4Narvekar N, Cameron S, Critchley H O, et al. Low-dose mifepristone inhibits endometrial pro-Liferation and up-regulates androgen recept-or[J]. J Clin Endo-crinol Metab, 2004,89 ( 5 ) : 2491-2497.
5Steinauer J, Pritts E A, Jackson R, et al. SystematiC review of mifepristone for the treatment of uterine leiomyomata[J]. Obstet Gynecol,2004,103 ( 6 ) : 1331-1336.
6Grunberg S M, Weiss M H, Russell C A, et al. Long-term administration of mifepristone ( RU486 ) : Clinical tolerance during extended treatment of meningioma [ J ]. Cancer Invest, 2006, 24 (8) :727-733.
7Taylor L J, Jackson T L, Reid J G, et al. The differential expression of oestrogen receptors, pro-gesterone receptors,Bcl-2 and Ki-67 in endo-metrial polyos[J]. BJOG,2003,110 ( 9 ) : 794-798.
8Inceboz U S, Nese N, Uyar Y, et al. Hormone receptor expressions and proliferation markers in postmenopausal endometrial polyps [ J]. Gynecol Obstet Znvest,2006,61 ( 1 ) :24-28.
9Sant'Ana de Almeida E C, Nogueira A A, Candido dos Reis F J, et al. Imm-unohistochemical expression of estrogen and progesterone recept-ors in endometrial polyps and adjacent endonetrium in postmenopausal women [ J ]. Maturitas, 2004,49:229-233.
10Lopes R G, Baracat E C, De Albuquerque N L C, et al. Analysis of estrogen and progesterone-receptor expression in endometrial polyps[J]. J Minim Invasive Gynecol, 2007,14 ( 3 ) :300-303.
